EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cellular antibody affinity–based CRISPR screening identifies JUNB as a broadly acting antiviral factor

Nicole C Waild iD, Jessica H Ciesla iD, Xenia L Schafer iD, Joshua Munger iD

Proceedings of the National Academy of Sciences · 07.04.2026 · 123 (14)

DOI: 10.1073/pnas.2534154123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.03.2026. Verfasst von Nicole C Waild und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642. Hauptthemen laut MEDLINE: Cytomegalovirus, Transcription Factors, Cytomegalovirus Infections. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR screening is a powerful approach to identify genetic perturbations that impact viral infection. However, most virus-focused CRISPR screens utilize selection strategies that limit the ability to identify genes important for infection. Here, we developed a CRISPR screening pipeline to identify cellular determinants of human cytomegalovirus (HCMV) infection based on virally induced remodeling of cellular antibody affinity (VIRCAA), which is scalable for large libraries and can identify cellular genes that impact HCMV infection at different life cycle stages. We utilized this pipeline to interrogate proteomic and transcriptomic datasets associated with the HCMV UL26 protein, which blocks antiviral signaling during infection. We find that JUNB drives antiviral gene expression, induces protein ISGylation, and suppresses diverse viral infections. Further, UL26 interacts with JUNB and suppresses JUNB-mediated condensation of viral DNA replication compartments. These results highlight the VIRCAA pipeline’s utility for identifying important determinants of viral infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytomegalovirusTranscription FactorsCytomegalovirus InfectionsHumansVirus ReplicationCRISPR-Cas SystemsViral ProteinsClustered Regularly Interspaced Short Palindromic Repeats

Stichwörter der Autor:innen

CRISPR screeningHCMVJUNBUL26cytomegalovirus

Substanzen

JunB protein, humanTranscription FactorsViral Proteins

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642.

ORCID-Profile: Nicole C Waild, Jessica H Ciesla, Xenia L Schafer, Joshua Munger

Förderung

  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)

Zitieren

APA

Waild, N. C., Ciesla, J. H., Schafer, X. L., & Munger, J. (2026). Cellular antibody affinity–based CRISPR screening identifies JUNB as a broadly acting antiviral factor. Proceedings of the National Academy of Sciences, 123(14). https://doi.org/10.1073/pnas.2534154123

Vancouver

Waild NC, Ciesla JH, Schafer XL, Munger J. Cellular antibody affinity–based CRISPR screening identifies JUNB as a broadly acting antiviral factor. Proceedings of the National Academy of Sciences. 2026;123(14). doi:10.1073/pnas.2534154123

BibTeX
@article{Waild2026,
  author = {Waild, Nicole C and Ciesla, Jessica H and Schafer, Xenia L and Munger, Joshua},
  title = {Cellular antibody affinity–based CRISPR screening identifies JUNB as a broadly acting antiviral factor},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {14},
  doi = {10.1073/pnas.2534154123}
}
Kostenlos starten →